Loading...

ZURA ZURA BIO LTD Management Changes 8-K Filing

ZR B

ZR

ZURA BIO LTD

(ZURA)

2024 8-K

Q3 Financial Results

Management Change

Severance Plan Update

Corporate Presentation Update

Press Release Issued

Financial Results Released

Financial Statements

Share Agreements

Corporate Presentation

Financial Results

Regulation FD Disclosure

Corporate Presentation

Regulation FD Disclosure

Regulation FD Disclosure

Regulation FD Disclosure

Q3 Financial Results

Regulation FD Disclosure

Annual Meeting Results

Management Change

Corporate Presentation

Regulation FD Disclosure

Share Surrender

Corporate Presentation

Q2 Financial Results

Warrant Exchange

Exchange Offer and Consent ...

Departure of CEO and Appoin...

Exchange Offer and Consent ...

Appointment, Salary Increase

Financial Results

Private Placement

Regulation FD Disclosure

Financial Results and CEO T...

Investor Conferences

Changes in Certifying Accou...

Investor Presentation

Departure of Directors and ...

Appointment of Executive Vi...

Regulation FD Disclosure

Regulation FD Disclosure

Investor Presentation

Appointment of Director

Regulation FD Disclosure

Earnings Reports

Investor Presentation

Investor Presentation

Equity Securities Sale

Shareholder Meeting Approval

Private Placement

Press Release and Investor ...

Regulation FD Disclosure

Service Agreements

Resignation of Officer

Business Combination

Press Release and Forward P...

Regulation FD Disclosure

Business Combination Approval

Listing Transfer

Amendment to Forward Purcha...

Business Combination Announ...

Business Combination Agreem...

External Links:

Zura Bio Ltd announced the departure of their Chief Medical Officer and Executive Vice President, Dr. Chris Cabell, and the appointment of Mr. Robert Lisicki as President and Chief Operating Officer.

AI Assistant

ZURA BIO LTD

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.